[{"Assets_0_Q3_USD":14242800.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-6454700.0,"NetIncomeLoss_1_Q3_USD":-3004800.0,"NetIncomeLoss_3_Q3_USD":-10267100.0,"StockholdersEquity_0_Q3_USD":10262800.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20171231","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180212"}]